Carnegie invests in new medtech company, Simplify Medical

Carnegie invests in new medtech company, Simplify Medical

December 2014: As reported in Business Insider, M.H. Carnegie & Co. is pursuing a “reverse brain drain” strategy through its medical technology investments.

Carnegie is buying innovative medical companies in America and turning them into Australian outfits that benefit from generous tax breaks for research and development. Simplify Medical is the latest of these investments.

Read More

Don’t starve tomorrow’s corporate champions

Don’t starve tomorrow’s corporate champions

May 2014: Mark Carnegie writes in The Australian that innovation and new business development are crucial for Australia’s economic health.

Government funding to put exciting new companies on their feet so they can compete in global markets is much the same as taxpayers funding the Australian Institute of Sport to train Olympic athletes. Just like with our investment in Olympic athletes, the community gets a huge return from government innovation programs.

Read More